Haoxi Health Technology Announces Annual General Meeting

Ticker: HAO · Form: 6-K · Filed: Dec 19, 2024 · CIK: 1954594

Haoxi Health Technology LTD 6-K Filing Summary
FieldDetail
CompanyHaoxi Health Technology LTD (HAO)
Form Type6-K
Filed DateDec 19, 2024
Risk Levellow
Pages1
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: shareholder-meeting, corporate-governance

Related Tickers: HAOX

TL;DR

Haoxi Health Tech (HAOX) is holding its annual shareholder meeting; check your mail for proxy info.

AI Summary

Haoxi Health Technology Limited filed a Form 6-K on December 19, 2024, to announce its upcoming Annual General Meeting. Attached as exhibits are the Notice of the Annual General Meeting and a Proxy Card for shareholders.

Why It Matters

This filing informs shareholders about the upcoming meeting where key company decisions will be made and provides them with the necessary documents to participate.

Risk Assessment

Risk Level: low — This is a routine administrative filing announcing a shareholder meeting, not indicating significant operational or financial changes.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

The purpose of this Form 6-K filing is to report the Notice of the Annual General Meeting of Shareholders and the accompanying Proxy Card for Haoxi Health Technology Limited.

When was this filing made?

This filing was made on December 19, 2024.

What are the attached exhibits?

The attached exhibits are Exhibit 99.1, which is a notice of the annual general meeting, and Exhibit 99.2, which is a proxy card.

What is the company's principal executive office address?

The company's principal executive office is located at Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District, Beijing, China.

Does Haoxi Health Technology Limited file annual reports under Form 20-F?

Yes, the registrant indicates it files annual reports under cover of Form 20-F.

Filing Stats: 419 words · 2 min read · ~1 pages · Grade level 13.4 · Accepted 2024-12-19 17:00:04

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Haoxi Health Technology Limited Date: December 19, 2024 By: /s/ Zhen Fan Name: Zhen Fan Title: Chief Executive Officer 2

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing